As-needed albuterol-budesonide reduces exacerbation risk at GINA Step 3 and Steps 4 and 5

The Journal of Allergy and Clinical Immunology: In Practice · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles